Novel Ophthalmic Drug Delivery

Human eye is protected by a unique anatomy and physiology. Therefore, it minimizes the transport of medication by traditional dosage forms to the eye and the therapeutic concentrations of drugs might not be maintained for long duration of time. Development of ocular drug delivery systems helped to place the medication on the anterior segment of the eye, and treat ocular infections for a prolonged period. Various biodegradable or non-biodegradable polymer intravitreal implants, have been widely investigated for the treatment of chronic vitreoretinal diseases. In the treatment of chronic diseases, the dosing frequency can be reduced by developing ocular drug delivery systems which provide controlled release of medication.

  • Liposomes
  • Niosomes
  • Nanoparticles
  • Iontophorosis
  • Corneal shields
  • Inserts
  • Drug embedded contact lenses
  • In-situ gel
  • Ocular wafers and films



 


    Related Conference of Novel Ophthalmic Drug Delivery

    September 16-17, 2025

    20th International Conference on Ophthalmology and Vision Science

    Amsterdam, Netherlands
    September 22-23, 2025

    8th International Eye and Vision Congress

    Amsterdam, Netherlands
    October 20-21, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    November 03-04, 2025

    39th European Ophthalmology Congress

    Rome, Italy
    January 12-13, 2026

    26th Global Ophthalmologists Annual Meeting

    London, UK
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain
    May 07-08, 2026

    7th International Conference on Optometry

    Paris, France
    May 25-26, 2026

    10th World Congress on Eye and Vision

    Madrid, Spain

    Novel Ophthalmic Drug Delivery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in